PCSK9 Inhibitors in the Progression of Aortic Stenosis

NCT03051360 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Aortic Valve Stenosis

Interventions

DRUG: PCSK9 Inhibitor [EPC]
DRUG: Placebos

Sponsor

Seoul National University Hospital